These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35618993)

  • 1. Sleeve Gastrectomy Improves High-Fat Diet-Associated Hepatic Steatosis Independent of the Glucagon-like-Petpide-1 Receptor in Rats.
    Barron M; Hayes H; Fernando DG; Geurts AM; Kindel TL
    J Gastrointest Surg; 2022 Aug; 26(8):1607-1618. PubMed ID: 35618993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy.
    Garibay D; McGavigan AK; Lee SA; Ficorilli JV; Cox AL; Michael MD; Sloop KW; Cummings BP
    Endocrinology; 2016 Sep; 157(9):3405-9. PubMed ID: 27501183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor.
    Douros JD; Lewis AG; Smith EP; Niu J; Capozzi M; Wittmann A; Campbell J; Tong J; Wagner C; Mahbod P; Seeley R; D'Alessio DA
    Diabetes; 2018 Aug; 67(8):1504-1511. PubMed ID: 29759973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
    Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
    Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stapled, Long-Acting Xenopus GLP-1-Based Dual GLP-1/Glucagon Receptor Agonists with Potent Therapeutic Efficacy for Metabolic Disease.
    Han C; Sun Y; Yang Q; Zhou F; Chen X; Wu L; Sun L; Han J
    Mol Pharm; 2021 Aug; 18(8):2906-2923. PubMed ID: 34240881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
    Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
    Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of long acting GLP1R/GCGR agonist in a DIO and biopsy-confirmed mouse model of NASH suggest a beneficial role of GLP-1/glucagon agonism in NASH patients.
    Monfeuga T; Norlin J; Bugge A; Gaalsgaard ED; Prada-Medina CA; Latta M; Veidal SS; Petersen PS; Feigh M; Holst D
    Mol Metab; 2024 Jan; 79():101850. PubMed ID: 38065435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinchonine, a Potential Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic Steatohepatitis.
    Xue H; Xing HJ; Wang B; Fu C; Zhang YS; Qiao X; Guo C; Zhang XL; Hu B; Zhao X; Deng LJ; Zhu XC; Zhang Y; Liu YF
    Drug Des Devel Ther; 2023; 17():1417-1432. PubMed ID: 37197367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
    Carmody JS; Muñoz R; Yin H; Kaplan LM
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes recurrence after metabolic surgeries correlates with re-impaired insulin sensitivity rather than beta-cell function.
    Liu T; Zhong MW; Liu Y; Sun D; Wei M; Huang X; Cheng YG; Wu QZ; Wu D; Zhang XQ; Wang KX; Hu SY; Liu SZ
    World J Gastroenterol; 2017 May; 23(19):3468-3479. PubMed ID: 28596682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sleeve gastrectomy on body weight, food intake, glucose tolerance, and metabolic hormone level in two different rat models: Goto-Kakizaki and diet-induced obese rat.
    Trung VN; Yamamoto H; Yamaguchi T; Murata S; Akabori H; Ugi S; Maegawa H; Tani T
    J Surg Res; 2013 Nov; 185(1):159-65. PubMed ID: 23746960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-dependent manner.
    Blevins JE; Honeycutt MK; Slattery JD; Goldberg M; Rambousek JR; Tsui E; Dodson AD; Shelton KA; Salemeh TS; Elfers CT; Chichura KS; Ashlaw EF; Zraika S; Doyle RP; Roth CL
    Front Endocrinol (Lausanne); 2024; 15():1432928. PubMed ID: 39104812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired brain glucose metabolism in glucagon-like peptide-1 receptor knockout mice.
    Li H; Fang Y; Wang D; Shi B; Thompson GJ
    Nutr Diabetes; 2024 Oct; 14(1):86. PubMed ID: 39389952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression.
    Zhou D; Chen YW; Zhao ZH; Yang RX; Xin FZ; Liu XL; Pan Q; Zhou H; Fan JG
    Exp Mol Med; 2018 Dec; 50(12):1-12. PubMed ID: 30510243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
    Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity-related vascular dysfunction persists after weight loss and is associated with decreased vascular glucagon-like peptide receptor in female rats.
    Kiernan R; Persand D; Maddie N; Cai W; Carrillo-Sepulveda MA
    Am J Physiol Heart Circ Physiol; 2022 Aug; 323(2):H301-H311. PubMed ID: 35749717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel role of GLP-1 receptor signaling in energy expenditure during chronic high fat diet feeding in rats.
    Krieger JP; Langhans W; Lee SJ
    Physiol Behav; 2018 Aug; 192():194-199. PubMed ID: 29654813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Sleeve Gastrectomy on Glucose Metabolism and Glucagon-Like Peptide 1 in Goto-Kakizaki Rats.
    Li L; Wang X; Bai L; Yu H; Huang Z; Huang A; Luo Y; Wang J
    J Diabetes Res; 2018; 2018():1082561. PubMed ID: 29670912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effect by which gastric plication and sleeve gastrectomy procedures alter metabolic and physical parameters in an obese type 2 diabetes rodent model.
    Ye M; Huang R; Min Z; Zhang P; Wang T; Yu B
    Surg Obes Relat Dis; 2017 Nov; 13(11):1819-1828. PubMed ID: 28645541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of somatostatin enhances the long-term metabolic outcomes of sleeve gastrectomy in mice.
    Kleiman D; Arad Y; Azulai S; Baker A; Bergel M; Elad A; Haran A; Hefetz L; Israeli H; Littor M; Permyakova A; Samuel I; Tam J; Ben-Haroush Schyr R; Ben-Zvi D
    Mol Metab; 2024 Aug; 86():101979. PubMed ID: 38945296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.